A. R. Far
发表
G. Moeck,
F. Arhin,
Stephane Ciblat,
2010,
Bioorganic & medicinal chemistry letters.
Hugo Poirier,
D. Delorme,
Jing Liu,
2008,
Journal of medicinal chemistry.
G. Moeck,
F. Arhin,
D. Lehoux,
2012
.
G. Patti,
J. Schaefer,
S. Kim,
2009,
Journal of molecular biology.
D. Kallend,
P. Wijngaard,
D. Lehoux,
2022,
Toxicology and applied pharmacology.
J. Rebek,
A. R. Far,
A. Shivanyuk,
2002,
Journal of the American Chemical Society.
J. Rebek,
P. Ballester,
A. R. Far,
2002,
Journal of the American Chemical Society.
Hugo Poirier,
D. Delorme,
G. McKay,
2006,
Bioorganic & medicinal chemistry letters.
A. R. Far,
2003
.
J. Pelletier,
P. Gros,
G. Moeck,
2006,
Bioorganic & medicinal chemistry letters.
D. Lehoux,
T. Parr,
A. R. Far,
2015,
Antimicrobial Agents and Chemotherapy.
Oritavancin exhibits dual mode of action to inhibit cell-wall biosynthesis in Staphylococcus aureus.
L. Cegelski,
Manmilan Singh,
J. Schaefer,
2008,
Journal of molecular biology.
Hugo Poirier,
D. Delorme,
G. McKay,
2006
.
J. Rebek,
D. Rudkevich,
Alexander Rang,
2002
.
Atul Kumar,
H. Mann,
T. Parr,
2011,
International Journal of Artificial Organs.
J. Pelletier,
P. Gros,
D. Delorme,
2006,
Bioorganic & medicinal chemistry.